[go: up one dir, main page]

EP1349548A4 - Methodes et compositions de traitement d'une parodontopathie - Google Patents

Methodes et compositions de traitement d'une parodontopathie

Info

Publication number
EP1349548A4
EP1349548A4 EP01994350A EP01994350A EP1349548A4 EP 1349548 A4 EP1349548 A4 EP 1349548A4 EP 01994350 A EP01994350 A EP 01994350A EP 01994350 A EP01994350 A EP 01994350A EP 1349548 A4 EP1349548 A4 EP 1349548A4
Authority
EP
European Patent Office
Prior art keywords
periodontopathy
compositions
treating
methods
treating periodontopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01994350A
Other languages
German (de)
English (en)
Other versions
EP1349548A2 (fr
Inventor
George D Hartman
Sevgi B Rodan
Gideon A Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1349548A2 publication Critical patent/EP1349548A2/fr
Publication of EP1349548A4 publication Critical patent/EP1349548A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP01994350A 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie Ceased EP1349548A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25944101P 2001-01-03 2001-01-03
US259441P 2001-01-03
PCT/US2001/049638 WO2002053099A2 (fr) 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie

Publications (2)

Publication Number Publication Date
EP1349548A2 EP1349548A2 (fr) 2003-10-08
EP1349548A4 true EP1349548A4 (fr) 2004-06-02

Family

ID=22984959

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01994350A Ceased EP1349548A4 (fr) 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie

Country Status (5)

Country Link
EP (1) EP1349548A4 (fr)
JP (1) JP2004517853A (fr)
AU (1) AU2002246757B2 (fr)
CA (1) CA2432504A1 (fr)
WO (1) WO2002053099A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
HUE063437T2 (hu) 2013-09-24 2024-01-28 Fujifilm Corp Nitrogént tartalmazó vegyületet vagy sóját vagy fémkomplexét tartalmazó gyógyászati készítmény
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417094D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031099A1 (fr) * 1997-12-17 1999-06-24 Merck & Co., Inc. Antagonistes du recepteur de l'integrine
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
WO2000006169A1 (fr) * 1998-07-29 2000-02-10 Merck & Co., Inc. Antagonistes des recepteurs de l'integrine
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
WO2000072801A2 (fr) * 1999-06-02 2000-12-07 Merck & Co., Inc. Antagonistes du recepteur de l'alpha v integrine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031099A1 (fr) * 1997-12-17 1999-06-24 Merck & Co., Inc. Antagonistes du recepteur de l'integrine
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
WO2000006169A1 (fr) * 1998-07-29 2000-02-10 Merck & Co., Inc. Antagonistes des recepteurs de l'integrine
WO2000072801A2 (fr) * 1999-06-02 2000-12-07 Merck & Co., Inc. Antagonistes du recepteur de l'alpha v integrine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02053099A3 *

Also Published As

Publication number Publication date
WO2002053099A3 (fr) 2002-09-12
CA2432504A1 (fr) 2002-07-11
WO2002053099A2 (fr) 2002-07-11
AU2002246757B2 (en) 2006-02-02
EP1349548A2 (fr) 2003-10-08
JP2004517853A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
EP1446114A4 (fr) Compositions et methodes de traitement de l'osteoporose
EP1438062A4 (fr) Methodes et compositions pour le traitement de lesions cutanees
EP1796666A4 (fr) Methodes et compositions de traitement de l'hyperlipidemie
EP1265913A4 (fr) Caracterisation d'interactions ligands-grp94 et methodes de purification, de criblage et de traitement associees
EP1663259A4 (fr) Compositions et methodes de traitement du cancer
DE60129522D1 (de) Gipszusammensetzungen und dazugehörende verfahren
ATE430555T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
EP1576110A4 (fr) Compositions inhibant la migration cellulaire et methodes et compositions pour le traitement du cancer
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
DE60227095D1 (de) Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
EP1480658A4 (fr) Procedes concernant le traitement d'une affection vasculaire
MA26207A1 (fr) Compositions de traitement de l'eau.
DE122009000025I1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
EP1461076A4 (fr) Methodes et compositions permettant de traiter des lesions de l'epithelium respiratoire
EP1089731A4 (fr) Compositions et methodes de traitement d'une cholesterolemie elevee
EP1532390A4 (fr) Gaine d'inversion et composantes de gaine pour conduits
FI20011403L (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
EP1499328A4 (fr) Methodes de traitement de l'enterocolite necrosante neonatale
DE69918842D1 (de) Desinfektionszusammensetzungen und verfahren
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
PL357674A1 (pl) Kompozycje i sposoby leczenia zaburzeń związanychz hiperlipidemią
EP1089732A4 (fr) Compositions et methodes de traitement d'une cholesterolemie elevee
EP1395215A4 (fr) Compositions d'acide quinolone carboxylique et methodes de traitement associees
EP1267903A4 (fr) Methodes de traitement du glaucome
EP1455841A4 (fr) Compositions et methodes associees a l'osteopontine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030804

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040421

17Q First examination report despatched

Effective date: 20040824

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20060101